Public Higher Education Bulletin

Flowonix's Prometra Intrathecal Pump is the only device available today for intrathecal morphine administration in patients with cancer-related and non-malignant chronic intractable pain that has unrestricted FDA labeling status.

The Prometra Pump? has a unique Precision Dosing System (PDS) that is designed to accurately and reliably deliver medicine minimizing the effect of reservoir volume or environmental factors including temperature and pressure. The PDS provides physicians with micro-dosing capabilities. With a 10+ year battery life, fewer pump replacement procedures may be required. The pump is anchored by incorporating a suture ring onto the pump, designed to provide a lower rate of suture complications and to prevent tissue ingrowth, which can complicate the process of pump replacement. To enhance the safety of refills, palpation of the port is improved by incorporating a 3mm raised ridge and wider opening ? 61% wider than previous pumps. The silicone in the septum is rated to withstand an average of 1,000 punctures of the refill septum. For safety, the catheter access port and needle are designed to be incompatible with the refill needle and port. The pump features a ?sutureless? connection with the redundant catheter lock that is able to resist over one pound of pull-out force. The Flexible Catheter Stem ensures the catheter remains connected to the pump. This is vital, as patients often bend and stress the connection. The flexible pump stem is designed to both be easier to initially connect during implant and to help prevent loss to the integrity of the connection post-operatively.

The University has determined that this purchase is only economically available from this source because the item or service is copyrighted or patented and is not available except from the holder of the copyright or patent.